SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-086030
Filing Date
2023-08-01
Accepted
2023-08-01 06:46:06
Documents
16
Period of Report
2023-08-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2322190d1_8k.htm   iXBRL 8-K 33881
2 EXHIBIT 99.1 tm2322190d1_ex99-1.htm EX-99.1 517918
3 EXHIBIT 99.2 tm2322190d1_ex99-2.htm EX-99.2 540884
8 GRAPHIC tm2322190_ex99-1img01.jpg GRAPHIC 13020
  Complete submission text file 0001104659-23-086030.txt   1404409

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA mrk-20230801.xsd EX-101.SCH 4141
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mrk-20230801_def.xml EX-101.DEF 27973
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE mrk-20230801_lab.xml EX-101.LAB 38099
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mrk-20230801_pre.xml EX-101.PRE 26585
10 EXTRACTED XBRL INSTANCE DOCUMENT tm2322190d1_8k_htm.xml XML 7602
Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Filer) CIK: 0000310158 (see all company filings)

IRS No.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-06571 | Film No.: 231129566
SIC: 2834 Pharmaceutical Preparations